{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:50:26Z","timestamp":1790369426154,"version":"4.1.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:p>After the initial identification of the H1N1 pandemic influenza strain in Mexico in April 2009 and its subsequent global spread, several monovalent influenza vaccines were developed as part of the pandemic response. Three of these vaccines, Pandemrix, Arepanrix and Focetria were adjuvanted. One of these, the AS03-adjuvanted Pandemrix vaccine, was primarily used in Europe. Following widespread Pandemrix vaccine administration in Scandinavia, an increased risk of narcolepsy was noted in observational studies. Subsequently, this increased risk was also reported in other European countries as well. In contrast, studies from Canada of a similar AS03-adjuvanted vaccine, Arepanrix, did not demonstrate a similar increased risk of narcolepsy. No studies have identified an increased risk of narcolepsy following the MF59-adjuvanted Focetria vaccine. For many potential pandemic influenza strains, adjuvants might be required to solicit a protective immune response. Thus, it is critical that we understand the nature of the association between adjuvanted vaccine receipt and narcolepsy. Here, we present a potential hypothesis for narcolepsy seen during the 2009 H1N1 pandemic in AS03-adjuvanted influenza vaccine recipients.<\/jats:p>","DOI":"10.1097\/inf.0000000000002398","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T12:20:46Z","timestamp":1563193246000},"page":"873-876","source":"Crossref","is-referenced-by-count":27,"title":["Narcolepsy and Pandemic Influenza Vaccination"],"prefix":"10.1097","volume":"38","author":[{"given":"Kathryn","family":"Edwards","sequence":"first","affiliation":[{"name":"Division of Pediatric Infectious Diseases, Vanderbilt University Medical Center, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Henri","family":"Lambert","sequence":"additional","affiliation":[{"name":"Centre of Vaccinology, University of Geneva, Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[{"name":"Divison of Infectious Diseases, Cincinnati Children\u2019s Hospital, Cincinnati, Ohio."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1016\/j.vaccine.2010.03.072","article-title":"Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for 2009 pandemic influenza A(H1N1) vaccination.","volume":"28","author":"Chlibek","year":"2010","journal-title":"Vaccine"},{"key":"R4-20230912","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/joim.12391","article-title":"A coordinated cross-disciplinary research initiative to address an increased incidence of narcolepsy following the 2009\u20132010 Pandemrix vaccination programme in Sweden.","volume":"278","author":"Feltelius","year":"2015","journal-title":"J Intern Med"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"e33723","DOI":"10.1371\/journal.pone.0033723","article-title":"Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland.","volume":"7","author":"Partinen","year":"2012","journal-title":"PLoS One"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.","volume":"343","author":"Bardage","year":"2011","journal-title":"BMJ"},{"key":"R7-20230912","doi-asserted-by":"crossref","first-page":"f794","DOI":"10.1136\/bmj.f794","article-title":"Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A\/H1N1 2009 influenza vaccine: retrospective analysis.","volume":"346","author":"Miller","year":"2013","journal-title":"BMJ"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"e33536","DOI":"10.1371\/journal.pone.0033536","article-title":"AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland.","volume":"7","author":"Nohynek","year":"2012","journal-title":"PLoS One"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.sleep.2017.02.026","article-title":"Retrospective multicenter matched case-control study on the risk factors for narcolepsy with special focus on vaccinations (including pandemic influenza vaccination) and infections in Germany.","volume":"34","author":"Oberle","year":"2017","journal-title":"Sleep Med"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2807\/1560-7917.ES2014.19.17.20789","article-title":"Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland April 2009\u2013December 2010.","volume":"19","author":"O\u2019Flanagan","year":"2014","journal-title":"Euro Surveill"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.vaccine.2017.02.053","article-title":"Narcolepsy and hypersomnia in Norwegian children and young adults following the influenza A(H1N1) 2009 pandemic.","volume":"35","author":"Trogstad","year":"2017","journal-title":"Vaccine"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"e108489","DOI":"10.1371\/journal.pone.0108489","article-title":"Risk of narcolepsy associated with inactivated adjuvanted (AS03) A\/H1N1 (2009) pandemic influenza vaccine in Quebec.","volume":"9","author":"Montplaisir","year":"2014","journal-title":"PLoS One"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.smrv.2017.06.006","article-title":"Incidence of narcolepsy after H1N1 influenza and vaccinations: systematic review and meta-analysis.","volume":"38","author":"Sarkanen","year":"2018","journal-title":"Sleep Med Rev"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-6445-1_1","article-title":"Overview of vaccine adjuvants: introduction, history, and current status.","volume":"1494","author":"Shah","year":"2017","journal-title":"Methods Mol Biol"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMra1500587","article-title":"Narcolepsy.","volume":"373","author":"Scammell","year":"2015","journal-title":"N Engl J Med"},{"key":"R18-20230912","doi-asserted-by":"crossref","first-page":"6202","DOI":"10.1016\/j.vaccine.2018.08.008","article-title":"Narcolepsy and adjuvanted pandemic influenza A (H1N1) 2009 vaccines\u2014multi-country assessment.","volume":"36","author":"Weibel","year":"2018","journal-title":"Vaccine"},{"key":"R19-20230912","article-title":"Narcolepsy and 2009 H1N1 pandemic vaccine in Taiwan.","author":"Huang","year":"2018","journal-title":"Sleep Med"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"e0187305","DOI":"10.1371\/journal.pone.0187305","article-title":"Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases.","volume":"12","author":"Luo","year":"2017","journal-title":"PLoS One"},{"key":"R21-20230912","first-page":"SR35","article-title":"Assessment of pregnancy outcomes in Czech and Slovak women with narcolepsy.","volume":"16","author":"Maurovich-Horvat","year":"2010","journal-title":"Med Sci Monit"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"E12323","DOI":"10.1073\/pnas.1818150116","article-title":"Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy.","volume":"115","author":"Luo","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.vaccine.2014.01.057","article-title":"The link between genetic variation and variability in vaccine responses: systematic review and meta-analyses.","volume":"32","author":"Posteraro","year":"2014","journal-title":"Vaccine"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.chom.2013.03.010","article-title":"Virus infections in the nervous system.","volume":"13","author":"Koyuncu","year":"2013","journal-title":"Cell Host Microbe"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems.","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"E368","DOI":"10.1073\/pnas.1521463112","article-title":"H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice.","volume":"113","author":"Tesoriero","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"10956","DOI":"10.1073\/pnas.1603325113","article-title":"CD8 T cell-mediated killing of orexinergic neurons induces a narcolepsy-like phenotype in mice.","volume":"113","author":"Bernard-Valnet","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/ana.22587","article-title":"Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.","volume":"70","author":"Han","year":"2011","journal-title":"Ann Neurol"},{"key":"R29-20230912","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1212\/WNL.0000000000000987","article-title":"Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States.","volume":"83","author":"Duffy","year":"2014","journal-title":"Neurology"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"419","DOI":"10.5664\/jcsm.6494","article-title":"Listening to the patient voice in narcolepsy: diagnostic delay, disease burden, and treatment efficacy.","volume":"13","author":"Maski","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"R31-20230912","doi-asserted-by":"crossref","first-page":"e68402","DOI":"10.1371\/journal.pone.0068402","article-title":"No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.","volume":"8","author":"Mel\u00e9n","year":"2013","journal-title":"PLoS One"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/irv.12074","article-title":"Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.","volume":"7","author":"Van Kerkhove","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"e0151575.g","DOI":"10.1371\/journal.pone.0151575","article-title":"Twin peaks: A\/H1N1 pandemic influenza virus infection and vaccination in Norway, 2009\u20132010.","volume":"11","author":"Van Effelterre","year":"2016","journal-title":"PLoS One"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006454-201908000-00023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:55:34Z","timestamp":1694559334000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201908000-00023"}},"subtitle":["What We Need to Know to be Ready for the Next Pandemic"],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002398","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}